Randomized, Multicenter, Warfarin-Controlled Phase II Study of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation-Reference-Cited by-同舟云学术

Randomized, Multicenter, Warfarin-Controlled Phase II Study of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation

Published:2012 Issue:8 Volume:76 Page:1840-1847
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Yamashita Takeshi¹¹,Koretsune Yukihiro²²,Yasaka Masahiro³³,Inoue Hiroshi⁴⁴,Kawai Yohko⁵⁵,Yamaguchi Takenori⁶⁶,Uchiyama Shinichiro⁷⁷,Matsumoto Masayasu⁸⁸,Ogawa Satoshi⁹⁹

Affiliation:

1. Division of Cardiology, The Cardiovascular Institute

2. Clinical Research Institute, National Hospital Organization Osaka National Hospital

3. Department of Cerebrovascular Disease, National Hospital Organization Kyushu Medical Center

4. Second Department of Internal Medicine, University of Toyama

5. Preventive Health Examination Center, International University of Health and Welfare

6. Cerebrovascular Division, National Cerebral and Cardiovascular Center

7. Department of Neurology, Tokyo Women's Medical University School of Medicine

8. Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical Sciences

9. Department of Medicine, International University of Health and Welfare Mita Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/76/8/76_CJ-11-1140/_pdf

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can edoxaban be used at extremes of bodyweight and in patients with a creatinine clearance ≥95 ml/min? – A population pharmacokinetic analysis;Thrombosis Research;2024-10

2. Distribution of anti‐factor Xa activity in patients with nonvalvular atrial fibrillation receiving 15 mg dose of edoxaban;Journal of Arrhythmia;2024-08-27

3. Oral anticoagulant therapy in older adults;Thrombosis Research;2024-06

4. Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?;The Pharmacogenomics Journal;2024-03-05

5. Study Design of a Brazilian Observational Study of Edoxaban in Patients with Atrial Fibrillation (EdoBRA);Arquivos Brasileiros de Cardiologia;2024